Showing results (71-80 of 114) with videos related to
Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2011
Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemiaJacqueline M Tromp, Christian R Geest, Esther C W Breij, et al.Blood|September 28, 2011
CD40 stimulation sensitizes CLL cells to lysosomal cell death induction by type II anti-CD20 mAb GA101Margot Jak, Gregor G W van Bochove, Eric A Reits, et al.Leukemia & Lymphoma|December 17, 2014
Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemiaSanne H Tonino, Chantal E Mulkens, Jacoline van Laar, et al.Cell Cycle (Georgetown, Tex.)|July 28, 2019
The NEDD8-activating enzyme inhibitor MLN4924 induces DNA damage in Ph+ leukemia and sensitizes for ABL kinase inhibitorsMahnoush Bahjat, Guus de Wilde, Tijmen van Dam, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 28, 2012
CD70-driven costimulation induces survival or Fas-mediated apoptosis of T cells depending on antigenic loadFelix M Wensveen, Peter-Paul A Unger, Natasja A M Kragten, et al.Blood|December 7, 2011
BH3-only protein Noxa regulates apoptosis in activated B cells and controls high-affinity antibody formationFelix M Wensveen, Ingrid A M Derks, Klaas P J M van Gisbergen, et al.Blood|July 1, 2020
Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLLMarco V Haselager, Karoline Kielbassa, Johanna Ter Burg, et al.Journal for Immunotherapy of Cancer|June 26, 2020
CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cellsAnne W J Martens, Susanne R Janssen, Ingrid A M Derks, et al.The Journal of Clinical Investigation|December 30, 2009
CD20 deficiency in humans results in impaired T cell-independent antibody responsesTaco W Kuijpers, Richard J Bende, Paul A Baars, et al.Leukemia|January 19, 2023
Chronic lymphocytic leukemia presence impairs antigen-specific CD8<sup>+</sup> T-cell responses through epigenetic reprogramming towards short-lived effectorsAnne W J Martens, Inga Kavazović, Mia Krapić, et al.Pageof 12